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Apathy is one of the most common behavioral symptoms of dementia; it is one of the salient features of behavioral variant of
frontotemporal dementia (bvFTD) but is also very frequent in Alzheimer’s disease. This preliminary investigation was aimed
at assessing the type of apathy-related symptoms in a population of bvFTD and AD subjects showing comparable apathy
severity. Each patient underwent a comprehensive neuropsychological assessment; behavioral changes were investigated by the
neuropsychiatric inventory (NPI), using the NPI-apathy subscale to detect apathetic symptoms. At univariate analysis, bvFTD
subjects showed lack of initiation (χ2 = 4.602, p = 0.032), reduced emotional output (χ2 = 6.493, p = 0.008), and reduced
interest toward friends and family members (χ2 = 4.898, p = 0.027), more frequently than AD subjects. BvFTD displayed higher
scores than AD on NPI total score (p = 0.005) and on subscales assessing agitation (p = 0.004), disinhibition (p = 0.007) and
sleep disturbances (p = 0.025); conversely, AD subjects were more impaired on memory, constructional abilities, and attention.
On multivariate logistic regression, reduced emotional output was highly predictive of bvFTD (OR = 18.266; p = 0.008). Our
preliminary ﬁndings support the hypothesis that apathy is a complex phenomenon, whose clinical expression is conditioned by
the site of anatomical damage. Furthermore, apathy proﬁle may help in diﬀerentiating bvFTD from AD.
1.Introduction
Apathy has been repeatedly reported to be one of the most
common noncognitive symptoms of dementia [1–3]. Fre-
quency and severity of apathy vary across diﬀerent dementia
subtypes; it is the most common behavioral symptom of
behavioral variant of frontotemporal dementia (bvFTD),
with reported prevalence ranging from 62 to 89% of patients
[4]; the prevalence of apathy in AD ranges from 25 to 88%
[5, 6] with a trend to increase with disease severity [7]. When
severity was directly compared, higher levels of apathy have
been reported in bvFTD than in AD [8–11]. The functional
and neuroanatomical substrates of apathy seem to diﬀer
between AD and bvFTD. In bvFTD, apathy severity has been
associated with orbitofrontal abnormalities, both in MRI
[12]andP ET[13]studies,andwithvolumelossinthedorsal
anteriorcingulateanddorsolateralprefrontalcortex[14].On
the other hand, in AD apathy severity has been connected to
neuroﬁbrillary tangles density in the anterior cingulate gyrus
[15] and to grey matter atrophy in the anterior cingulate
and in the left medial frontal cortex [16]. These ﬁndings
were conﬁrmed by a PET study showing the association of
apathy with hypometabolism in the bilateral anterior cingu-
late gyrus and medial orbitofrontal cortex [17].
On these grounds, it is quite clear that there is not a com-
plete overlap between the anatomical substrates of apathy in
bvFTD and AD, even though most of the previous studies
haveregardedapathyasanunitarycomplex.However,Marin
[18–20] has proposed that apathy, deﬁned as a “lack of moti-
vation not attributable to diminished level of consciousness,
cognitive impairment or emotional distress,” is a composite
phenomenon, whose speciﬁc symptomatology can be dis-
sected. “Aﬀective-emotional” apathy would be characterized
by a reduced ability to associate emotions to behaviors,2 Current Gerontology and Geriatrics Research
manifesting as indiﬀerence or lack of empathy; “behavioral
apathy” would be characterized by a reduction in sponta-
neous generation of motor patterns, so the patients need to
bepromptedtoperformphysicalactivities;ﬁnally,“cognitive
apathy” would be characterized by an inactivation of goal-
directed cognitive activity manifested by the need of external
stimuli to start mental activity or speech [8, 18]. Levy and
Dubois [21]p r o p o s e dad i ﬀerent view of apathetic symp-
toms, stating that lack of motivation could be considered
a projective and nonmeasurable construct, whereas apathy
should be considered more correctly from a “behavioristic”
point of view. They deﬁned apathy as “the quantitative
reduction of self-generated voluntary and purposeful behav-
iors” [21]. Accordingly, they proposed that apathy would be
a pathology of voluntary action or goal-directed behavior,
caused by dysfunctions occurring at the level of elaboration,
execution, and control of goal-directed behavior [22]. The
phenomenological distinction proposed by Levy and Dubois
diﬀers only slightly from the initial one proposed by Marin
as they identiﬁed three dysfunctional domains: “aﬀective-
emotional,” “cognitive,” and “autoactivation”.
The distinction of “apathetic domains” may lead to the
identiﬁcation of speciﬁc neuroanatomical substrates for each
of them. As a general observation, the occurrence of apathy
is connected to damage of prefrontal cortex (PFC) and
basal ganglia [5, 21]; thus, the segregation of the PFC-basal
ganglia circuitry [23, 24] may represent the substrate of
the diﬀerent clinical phenotypes of apathy [21]: “emotional-
aﬀective” apathy may be related to the orbitomedial PFC
and ventral striatum; “cognitive apathy” may be associated
with dysfunction of lateral PFC and dorsal caudate nuclei;
deﬁcit of “autoactivation” may be due to bilateral lesions of
the internal portion of globus pallidus, bilateral paramedian
thalamic lesions, or the dorsomedial portion of PFC.
On these bases, it is conceivable that the apathetic symp-
toms shown by AD and bvFTD patients may be diﬀerent
from a qualitative point of view. This ﬁnding would also
explain the diﬀerent neuroanatomic substrates of apathyi-
dentiﬁed by structural and functional neuroimaging in
bvFTD [12–14] and AD [15–17].
This hypothesis has been previously explored by Chow
et al. [8]. These authors studied a large sample of AD and
FTD subjects and reported that the clinical proﬁle of apathy
in FTD and AD wassubstantiallyoverlapping. However, they
observedthatapathywasassociatedwithdiﬀerentbehavioral
changes among the two groups of patients, namely compul-
sions and impulsivity in FTD, and dysphoria in AD.
The present preliminary investigation was aimed at
assessing the apathy proﬁle of bvFTD and AD and to assess
its possible role in the diﬀerential clinical diagnosis, as com-
pared to other behavioral changes and diﬀerent neuropsy-
chological patterns.
2.MaterialsandMethods
2.1. Subjects. Forty-two subjects fulﬁlling clinical diagnostic
criteria for behavioral variant of frontotemporal dementia
[25] were screened among subjects referring to our Neu-
ropsychology Unit for memory and behavioral disorders.
Exclusion criteria were, in addition to those provided by
the corresponding diagnostic criteria, the absence of an in-
formed caregiver, unavailability of neuroradiological exami-
nation, and/or the assumption of psychotropic drugs within
two months prior to the clinical assessment. Following these
exclusion criteria, four patients were excluded in conse-
quence of lack of a suﬃciently informed caregiver; three
subjects were excluded because neuroimaging examinations
were not available; ﬁnally, seven subjects were assuming
psychotropic drugs (typical antipsychotics: 1 subject; atyp-
ical antipsychotics: 1 subject; antidepressants: 4 subjects;
cholinesterase inhibitors: 1 subject) during the two months
prior to our assessment (see Figure 1).
Additionally, twenty subjects aﬀected by probable AD
according to NINDCS-ADRDA criteria [26], matched to the
bvFTD group for age and educational level, were selected.
Furthermore, AD patients were matched to bvFTD patients
even for apathy level in order to avoid an overestimation
of symptoms frequency due to diﬀerent levels of disease
severity. Each patient underwent a complete medical and
neurological examination. In order to be enrolled into the
studysubjectshadtoshowonbrainMRItheclassicalpattern
of atrophy of bvFTD (frontal and temporal lobe atrophy)
or AD (hippocampal atrophy) and display hypoperfusion in
frontal or frontotemporal regions (bvFTD) or in temporo-
parietal and precuneus regions (AD) on HMPAO-SPECT.
The diagnosis was conﬁrmed after 6 and 12 months of
clinical follow-up.
2.2. Neuropsychological Assessment. Each patient underwent
the Mini-Mental State Examination (MMSE) [27] and the
Clinical Dementia Rating (CDR) scale [28]. Furthermore,
patients were administered an extensive neuropsychological
examination, including tasks of visual and verbal memory
(Rey’s Auditory Verbal Learning Test (RAVLT) including
subtests of immediate and delayed recall and forced-choice
recognition [29], Rey-Osterrieth Complex Figure (ROCF)
recall [30]); phonological (F, A, S) and semantic (birds,
furniture) verbal ﬂuency (resp., PVF and SVF); confronta-
tion naming of pictures of objects and actions; copy of
Rey’s complex ﬁgure [30], executive functions (Stroop’s test
[31], Frontal Assessment Battery (FAB) [32]); visual atten-
tion (Multiple Features Targets Cancellation (MFTC) [33]);
abstract reasoning (Raven’s Coloured Progressive Matrices—
PM’47 [29]); copy of pictures with and without landmarks
[29, 34].
2.3. Behavioral Assessment. Behavioralfeatureswere assessed
by means of the Neuropsychiatric Inventory (NPI) [35],
a well-known informant-based 12-domains questionnaire
requiring the interview of the patient’s primary caregiver
(usually the spouse). The interview assessed the presence,
frequency, and severity of twelve behavioral symptoms (viz.,
delusions, hallucinations, agitation, depression, anxiety, ela-
tion/euphoria, apathy, disinhibition, irritability, abnormal
motor behavior, sleep disturbances, and appetite distur-
bances) commonly observed in demented patients. For each
domain, the interview started with a screening questionCurrent Gerontology and Geriatrics Research 3
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Figure 1: patients’ selection work-ﬂow. bvFTD: behavioral variant of frontotemporal dementia; AD: Alzheimer’s disease.
aimed at assessing the presence of abnormality in a speciﬁc
behavior.Ifthecaregiverreportedanabnormalbehavior,this
wasfurtherexploredwithmorespeciﬁcquestions.Frequency
and severity were assessed separately. The total score ranged
from 0 (no abnormalities) to 12 (severe abnormalities).
The apathy investigation was conducted by means of
the NPI-apathy subscale which has been showed to be
psychometrically robust across the range of diﬀerent types of
dementia [36]. Information was gathered about the presence
of each subitem taken into account; the apathetic symptoms
were coded on a presence/absence basis. The choice of the
NPI-apathy subscale to assess apathetic symptoms was made
for three principal reasons. First of all, the NPI is a widely
used and well-known diagnostic tool, thus we were quite
convinced that the possible observation of clear diﬀerences
in apathy-related symptoms obtained by its administration
could be easily applied and replicated in clinical practice;
secondly, since the behavioral proﬁle of bvFTD is complex
and includes several typologies of disturbances, we reputed
that it would be useful to assess apathy and other behavioral
symptoms in a homogeneous way. Finally, the NPI-apathy
subscale,togetherwiththeApathyEvaluationScale,hasbeen
reported to be the most robust assessment scale for apathy in
patients with dementia [36].
2.4. Statistics. The small sample size and the use of discrete
variables (NPI scores) have led to the use of nonparametric
statistics; thus, comparison of continuous variable has been
performed using the Mann-Whitney U-test, whereas χ2-test
with Yates’ continuity correction was used to compare fre-
quencies.
In order to verify the reliability of ﬁndings obtained in
univariate statistics, a backward stepwise logistic regression
analysiswasperformed,settingdiagnosis(bvFTDversusAD)
as the dependent variable and variables with signiﬁcance
level<0.05atunivariateanalysesaspredictors.Thereliability
of the regression analysis was assessed using the method
described by Hosmer and Lemeshow [37]. Sensitivity, speci-
ﬁcity, negative predictive value, positive predictive value, and
area under the ROC curve (AROC) were determined for the
logistic regression model in order to assess its diagnostic
reliability. The signiﬁcance level was two-sided for each
statistical comparison.
3. Results
3.1. Sample Characteristics. Both bvFTD and AD patient
groups were equal in age (resp., 66.25 ± 8.737 years versus
69.30 ± 7.828 years; |z|=1.173, p = 0.241), education4 Current Gerontology and Geriatrics Research
Table 1: Comparison of neuropsychological performances of the two groups. Statistically signiﬁcant diﬀerences are indicated in bold;
confounders included in the logistic regression analysis are reported in italics. MMSE: Mini-Mental Sate examination; CDR: Clinical
Dementia Rating Scale; RAVLT: Rey’s Auditory Verbal Learning Test; MFTC: Multiple Features Targets Cancellation; ROCF: Rey-Osterrieth
Complex Figure.
bvFTD (N = 28) AD (N = 20)
Mean SD Mean SD |z| p
MMSE 19.07 8.789 17.85 4.368 1.445 0.148
CDR 1.78 0.815 1.48 0.659 1.183 0.237
RAVLT immediate
recall 20.59 12.858 17.45 7.702 1.005 0.315
RAVLT delayed recall 3.59 3.456 1.05 1.468 2.567 0.010
RAVLT recognition
accuracy 77.37 22.047 72.00 16.403 1.616 0.106
RAVLT false alarms 8.89 8.916 11.10 7.137 1.352 0.176
Phonological verbal
ﬂuency 15.64 15.887 14.00 10.141 0.367 0.714
Semantic verbal
ﬂuency 6.79 6.373 9.00 4.634 1.849 0.065
Raven’s colored
matrices 18.18 7.822 15.94 7.630 1.340 0.180
Cube copy 2.65 1.285 1.90 1.242 2.034 0.042
Cube copy with
landmarks 17.26 5.708 15.50 7.416 0.524 0.600
MFTC accuracy 80.71 24.424 73.33 19.538 1.401 0.161
MFTC time of
execution 125.79 72.971 170.03 57.792 2.130 0.033
MFTC false alarms 5.96 9.796 9.65 12.874 1.174 0.241
Frontal assessment
battery 7.88 6.124 8.30 2.726 0.199 0.842
Nouns denomination 17.85 8.198 23.01 4.382 2.180 0.029
Verbs denomination 13.52 7.223 16.95 5.562 1.492 0.136
ROCF copy 21.84 13.433 16.15 9.887 1.726 0.084
ROCF delayed
reproduction 6.25 5.958 4.44 3.808 1.067 0.286
Stroop:
interference/time 65.37 52.970 84.76 43.329 1.290 0.197
Stroop:
interference/errors 10.72 11.353 15.11 10.907 1.418 0.156
(11.29 ± 4.7 9 9y e a r sv e r s u s9 .30 ± 4.181 years; |z|=1.491,
p = 0.136), and clinical duration of the disease (51.68 ±
34.020 months versus 36.65 ± 19.773 months; |z|=1.600,
p = 0.110).Furthermore,therewerenodiﬀerencesinMMSE
and CDR mean scores (Table 1).
3.2. Neuropsychological Assessment. Table 1 displays results
of the neuropsychological evaluation. As expected, bvFTD
performed better than AD patients on an episodic memory
test (RAVLT delayed recall; p = 0.010) and on a test of
constructional praxis (ﬁgure copy, p = 0.042). Furthermore,
AD patient were slower than bvFTD patients on MFTC
(p = 0.033), whereas bvFTD patients performed worse
than AD patients on object naming (p = 0.029). Trendwise
signiﬁcance was observed for SVF (p = 0.065) and ROCF
copy (p = 0.084).
3.3. Behavioral Examination. As easily predictable, patients
aﬀected by bvFTD showed more pronounced behavioral
disturbances than AD (Table 2). In particular, bvFTD sample
obtained higher NPI total score (p = 0.005) and higher
scores on the subscales assessing agitation (p = 0.004),
disinhibition (p = 0.007), and sleep disturbances (0.028).
Statistical trends were detected also for euphoria (p =
0.056), abnormal motor behavior (p = 0.090), and appetite
disturbances (p = 0.092).
3.4. Apathetic Symptoms. Table 3 reports the frequency of
occurrence of the individual apathetic symptoms assessed
by the NPI apathy subscale. bvFTD patients showed more
frequently a reduction of conversation initiation (question
no. 2, p = 0.032), behaved less aﬀectionately and displayed
lower emotional output (question no. 3, p = 0.008), andCurrent Gerontology and Geriatrics Research 5
Table 2:Comparisonofbehavioralproﬁlesofthetwogroups.Statisticallysigniﬁcantdiﬀerencesareindicatedinbold;confoundersincluded
in the logistic regression analysis are reported in italics. NPI: Neuropsychiatric Inventory.
bvFTD (N = 28) AD (N = 20)
Mean SD Mean SD |z| p
NPI delusions 1.89 3.72 1.05 1.701 0.324 0.746
NPI hallucinations 0.18 0.55 0.45 1.395 0.473 0.636
NPI agitation 3.48 4.07 1.00 2.026 2.897 0.004
NPI depression 2.54 3.05 1.80 1.542 0.245 0.806
NPI anxiety 2.93 3.79 1.95 3.300 0.873 0.382
NPI euphoria 1.79 3.11 0.60 2.088 1.912 0.056
NPI apathy 5.79 3.48 4.30 2.774 1.458 0.145
NPI disinhibition 2.07 3.13 0.45 1.395 2.697 0.007
NPI irritability 4.00 4.07 1.95 2.417 1.792 0.073
NPI aberrant motor
behavior 3.29 4.23 1.20 2.215 1.697 0.090
NPI sleep
disturbances 2.58 2.56 0.90 1.619 2.239 0.025
NPI appetite
disturbances 4.79 4.53 2.60 3.393 1.687 0.092
NPI total score 3500 22.09 18.25 12.152 2.814 0.005
Table 3: Phenomenological features of apathy among FTD and AD subjects. Statistically signiﬁcant diﬀerences are indicated in bold.
bvFTD (N = 28) AD (N = 20)
N % N % χ2 p
(1) Does the patient seem less spontaneous and less active than usual? 4 14.3 4 20.0 0.017 0.896
(2) Is the patient less likely to initiate a conversation? 21 75.0 8 40.0 4.602 0.032
(3) Is the patient less aﬀectionate or lacking in emotions when
compared to his/her usual self? 19 67.9 5 25.0 6.943 0.008
(4) Does the patient contribute less to household chores? 17 60.7 11 55.0 0.010 0.921
(5) Does the patient seem less interested in the activities and plans of
others? 19 67.9 12 60.0 0.065 0.799
(6) Has the patient lost interest in friends and family members? 20 71.4 7 35.0 4.898 0.027
(7) Is the patient less enthusiastic about his/her usual interests? 20 71.4 11 55.0 0.752 0.241
(8) Does the patient show any other signs that he/she does not care
about doing new things? 15 53.6 6 30.0 1.763 0.184
showed lower interest toward friends and family members
(question no. 6, p = 0.027) than AD subjects. On the
other hand, reduction of activity (question no. 1), lower
participation in household chores (question no. 4), lost of
interest in the activities of other persons (question no. 5) and
in his/her own hobbies (question no. 7), and reduced care
about new things (question no. 8) were reported with similar
frequencies among the groups.
3.5. Multivariate Logistic Analysis. The logistic regression
model included at the beginning block neuropsychological
scores (RAVLT delayed recall, ﬁgure copy, MFTC time
of execution, and objects naming), behavioral data (NPI:
agitation, disinhibition, sleep disturbances, and NPI total
score), and presence of apathetic symptoms (“yes” responses
to NPI apathy subscale questions no. 2, 3, and 6). The
dependent variable was the diagnosis, and odds ratios (OR)
were calculated for the risk of bvFTD.
Theﬁnalmodel included MFTCtime ofexecution(OR =
0.975; 95%CI = 0.955−0.995; p = 0.016), “yes” response to
question no. 3 (OR = 18.266; 95%CI = 2.531–131.792; p =
0.008) of the NPI-apathy subscale, and the score obtained
on the objects naming (OR = 0.703; 95%CI = 0.551–0.896;
p = 0.004). Following Hosmer and Lemeshow’s method,
the model goodness-of-ﬁt was satisfactory (χ2 = 28.34; p =
0.947).
The diagnostic accuracy of the model was good; 81.25%
of the subjects were correctly classiﬁed, with sensitivity of
89.3%, speciﬁcity of 70.0%, PPV of 80.7%, and NPV of
82.3%; the AROC was 0.910.
4. Discussion
Apathy is a complex phenomenon, whose clinical architec-
turehasbeenextensivelyinvestigatedinrecentyears[18–22].
It also appears as the most common behavioral symptom6 Current Gerontology and Geriatrics Research
of dementia [1–3], especially in bvFTD [4]. Furthermore,
p r e v i o u ss t u d i e sr e p o r t e dt h a ts u b j e c t sa ﬀected by bvFTD
generally display higher levels of apathy as compared to
AD patients [8–11], without substantial diﬀerences from the
phenomenological point of view [8].
The main ﬁnding of the present study is the observation
of a diﬀerent distribution of apathetic symptoms between
bvFTD and AD subjects matched for disease severity (as
assessedbyMMSEandCDR)andforseverityoftheapathetic
symptomatology (as assessed by means of the total NPI-
apathy score). In our samples, subjects aﬀected by bvFTD
displayed higher frequency of “aﬀective” symptoms (NPI-
apathy questions: “is the patient less aﬀectionate or lacking
in emotions when compared to his/her usual self?”; “has the
patient lost interest in friends and family members?”), and a
reduction of “auto-activation” [21] (or “behavioral apathy,”
[18]) in comparison with AD sample.
The diﬀerent clinical expression of apathy among the
two groups of patients probably reﬂects the involvement
of diﬀerent anatomic substrates. Previous studies have
reported that in bvFTD apathy is associated with changes
in orbitofrontal cortex [12, 13], which, in turn, has been
postulatedtobetheanatomicalcorrelateof“aﬀective”apathy
[21]. Thus, it is possible that our observation may reﬂect an
alteration of orbitofrontal cortex and its connections with
subcortical nuclei (ventral striatum) that could be speciﬁc of
bvFTD. We did not ﬁnd such a dissociation as for the other
apathetic symptoms taken into account and this may reﬂect
the partial overlap of functional alterations between AD and
bvFTD, particularly in the anterior cingulate gyrus [14, 17].
“Aﬀective apathy” may be also regarded as the clinical
expression of personality changes in bvFTD; for example,
Sollberger et al. [38]r e p o r t e dt h a ts u b j e c t sw i t hF T Da n d
semantic dementia displayed a reduction in aﬃliative behav-
ior(lackofwarmth)andshowed,inalargesampleofsubjects
aﬀected by diﬀerent neurodegenerative diseases, an associa-
tion between “warmth” and several cortical and subcortical
righthemispherestructures(viz.orbitofrontalcortex,insular
cortex, amygdala, and hippocampal and parahippocampal
regions). This ﬁnding is of particular interest, since the
authors reported an association between lack of warmth
and cerebral structures related to reward mechanisms, and
“aﬀective apathy” has been regarded as consequence of the
inability to associate emotions to behaviors [18–20]. Analo-
gously, aﬀective apathy may be related to an impairment of
the so-called prosocial sentiments (such as guilt, pity, and
embarrassment), connected to lack of empathy; Moll et al.
[39] reported reduced social sentiments in bvFTD subjects;
this deﬁcit was related to hypometabolism in medial frontal
polar cortex and septal area.
The results of our study support the hypothesis that
apathy is a complex syndrome, with diﬀerent clinical expres-
sionsacr ossdiﬀerentpathologicalconditions.Onthebasisof
our ﬁndings, it is conceivable that diﬀerences in qualitative
aspects of apathy (and not in its severity) could be associated
with diﬀerences in the damage site, as previously reported
[21]. However, given the small size of our sample and the
slight (yet not statistically signiﬁcant) diﬀerence in overall
apathy severity, we are not able to rule out that the site of
damage may aﬀect also the severity of apathy.
Another interesting ﬁnding of the present study is that a
more detailed assessment of apathy, which is very common
in bvFTD and AD, could contribute in diﬀerentiating these
conditions. In fact, the presence of “aﬀective” apathy was
the only behavioral change able to distinguish bvFTD from
AD patients in the multivariate regression model. It must be
considered that we selected AD patients with apathy level
comparable to bvFTD. This methodological approach was
chosen because apathy is common in AD and is possibly
present in the early phase of the disease [5, 6], even in
MCI [40]. Therefore, we decided to explore the clinical
scenario of subjects showing signiﬁcant apathetic symptoms
in association with cognitive changes that may be considered
ar e l e v a n td i ﬀerential diagnostic challenge.
One could ﬁnd surprising that neither memory dis-
turbances nor executive functions were able to distinguish
AD from bvFTD. However, we have previously reported
that performances on typical executive tests may be similar
between bvFTD and AD [10] and memory disturbances are
commoninbvFTD.Furthermore,theexpectedcognitiveand
behavioral diﬀerences were conﬁrmed at univariate analysis.
AD subjects resulted signiﬁcantly in being more impaired in
episodic memory and constructional abilities, whereas they
displayed less behavioral disturbances. Thus, the association
of aﬀective apathy with bvFTD was strong enough to make
most of the other diﬀerences lose their predictive role.
Our ﬁndings are at variance with the study conducted
by Chow et al. [8] on the clinical features of apathy in FTD
and AD. They reported that the phenomenology of apathy
was similar between AD and FTD and that diﬀerences could
be found only in its correlates with other behavioral dis-
turbances. Nevertheless, in their study apathetic symptoms
assessed by NPI were arbitrarily subdivided on the basis of
Marin’smodelandahalfofthedomains(4outof8)werenot
unequivocally classiﬁed after expert consensus. Moreover,
the perspective of the present paper has been quite diﬀerent
from the one of Chow et al. since they reported that AD
subjects obtained lower scores on the NPI-apathy subscale
than FTD patients, whereas our study was carried out to
investigate diﬀerences in apathy proﬁle when apathy severity
was comparable. Finally, the FTD group enrolled by Chow et
al. included 39 (42% of the FTD group) subjects aﬀected by
Primary Progressive Aphasia who are characterized by less
severe and speciﬁc behavioral disturbances [10]. Therefore,
the results of this study are hardly comparable with those
previously reported by Chow et al. [8].
Obviously, our ﬁndings require conﬁrmation from inde-
pendent studies on larger series of subjects because the
relatively small sample of AD and FTD patients taken into
account in the present investigation can be considered as
the main weakness of our research; furthermore, only a
single question of the NPI-apathy subscale entered the ﬁnal
logistic regression model, alongside with the MFTC and
naming task scores, thus resizing the predictive value of
apathy-related symptoms in diﬀerential diagnosis between
bvFTD and AD. However, it is worth noting that the overall
diagnostic accuracy of the logistic regression model obtainedCurrent Gerontology and Geriatrics Research 7
in the present investigation (81.25%) is not far from results
of previous studies that reported a diagnostic accuracy of
about 85% on autopsy conﬁrmed series, using complex
neuropsychological battery [41].
The absence of data about the single-item reliability of
NPI-apathy subscale could be regarded as another limitation
of our study, leading to a cautious interpretation of the
results. Nevertheless, we are quite conﬁdent that results of
the present study support the view of apathy as a complex
phenomenon, encompassing several clinical expressions,
whose appearance is mainly related to the anatomical locus
of damage. Furthermore, a reﬁned investigation of apathy
features could be useful in distinguishing bvFTD from AD
when a relevant apathetic symptomatology is present.
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